top of page

Agenda

   Day 01   
   ( 29th July 2023 )  

01

 CNS + HEAD & NECK SESSION

  • Long-term Risk of Carotid Stenosis and Cerebrovascular Disease after Radiation Therapy for Head and Neck Cancer
  • Predictors of radiation necrosis and dose/volume tolerance of the brain after three-fraction radiosurgery for brain metastases: A large single-institutional analysis
  • A Phase II Study of Volume and Dose De-Intensification Following Transoral Robotic Surgery (TORS) and Neck Dissection for p16+ Oropharyngeal Squamous Cell Carcinoma
  • ctHPVDNA and Recurrence Risk in MC1675, a secondary analysis of a Phase III Evaluation of De-escalated Adjuvant Radiation Therapy (DART) versus Standard Adjuvant Treatment for HPV Associated Oropharyngeal Squamous Cell Carcinoma
  • MGMT Promotor Methylation Predicts Survival in Low-Grade and Anaplastic Gliomas after Alkylating Chemotherapy
  • Comparative evaluation of the sum of longest diameter measurements as per rectist 1.1 vs cect based volumetric estimation for response assessment in locally advanced head and neck cancer

02

 BREAST SESSION

  • NRG RTOG 1005: A Phase III Trial of Hypo fractionated Whole Breast Irradiation with Concurrent Boost Versus Conventional Whole Breast Irradiation plus Sequential Boost following Lumpectomy for High Risk Early-Stage Breast Cancer (PLENARY SESSION)
  • Accelerated Partial Breast Irradiation (2021) Using Five Daily Fractions: A Prospective, Phase II, Multi-centre Trial of Cosmetic Outcomes and Toxicity: Final Results
  • Ultra-accelerated photons, protons, or brachytherapy for favorable early breast cancer: long-term results of a 3-fraction partial breast irradiation trial
  • Concurrent Olaparib with radiotherapy in patients with triple negative breast cancer: final results of the RADIOPARP phase 1 trial
  • Radiotherapy Use and Incidence of Locoregional Recurrence in Patients with Favorable-Risk Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial

03

 GI SESSION 

  • Non-operative management is feasible and safe in patients with rectal cancer who achieve clinical complete response to short-course radiation therapy and consolidation chemotherapy
  • Radiotherapy Enhance the Immune Checkpoint Inhibitors Efficacy in advanced liver cancer
  • Multi-Institutional Comparison Of Ablative Radiation Therapy In 5 Versus 15-25 Fractions For Locally Advanced Pancreatic Cancer
  • Neoadjuvant Chemoradiotherapy Significantly Improved R0 Resection Rate in Unresectable Locally Advanced Colon Cancer: the Initial Analysis from the Randomized Controlled Phase 3 Trial.
  • Concurrent chemoradiation of different doses (50.4 Gy vs. 59.4 Gy) and different target field (ENI versus IFI) for locally advanced esophageal squamous cell carcinoma: results from a randomized, multicenter phase Ⅲ clinical trial

04

 GU SESSION 

  • Conventional vs Hypofractionated, radiotherapy for high-risk prostate cancer: 7-year outcomes of the randomized, non-inferiority, phase 3 PCS5 trial
  • The Influence of Pelvic Lymph Node Dissection Volumes on Clinical Outcomes in NRG/RTOG 0534
  • Multi-institutional matched comparison of radical cystectomy to trimodality therapy for muscle invasive bladder cancer (MIBC)
  • Long-term Outcomes of SABR to Primary Renal Cell Carcinoma: A Multicenter Analysis from IROCK (International Radiosurgery Oncology Consortium for Kidney)
  • Bladder Only Versus Bladder Plus Pelvic Lymph Node Chemoradiation for Muscle-Invasive Bladder Cancer
  • Predictive Value of Ga68-PSMA PETCT-Based Response to Neoadjuvant Androgen Deprivation Therapy in Node Positive Prostate Cancer Treated with Radical Radiotherapy

LUNCH

05

 THORAX & SARCOMA SESSION 

  • Pembrolizumab plus Concurrent Chemoradiation Therapy (cCRT) for Unresectable, Locally Advanced, Stage III NSCLC: KEYNOTE-799 2-Year Update
  • Effect of EGFR-TKIs Combined with Cerebral Radiotherapy on Prognosis of Patients with EGFR-Mutant Lung Adenocarcinoma with Brain Metastasis
  • Relationship Between Cardiac Dose and Overall Survival after Radiotherapy in a Large Cohort of Patients with Locally Advanced NSCLC
  • Prospective Single-arm Trial of preoperative 42.75 Gy in 15 fractions for soft tissue sarcoma of the extremity/trunk
  • Role of Adjuvant Regional Nodal Irradiation in Resected Melanoma: A Secondary Analysis of SWOG S1404
     

06

 STEREOTAXY SESSION 

  • Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiotherapy to Conventional Palliative External Beam Radiotherapy
  • Pre-Operative Versus Post-Operative Fractionated Stereotactic Radiotherapy for Patients with Brain Metastases: A Multi-Institutional Analysis
  • Stereotactic Body Radiation Therapy for High-Grade Malignant Epidural Spinal Cord Compression from Solid Tumor Metastases
  • Stereotactic Body Radiation Therapy versus Conventional External Beam Radiation Therapy for Painful Bone Metastases: A Systematic Review and Meta-analysis of Randomized Trials
  • Liver function preservation and outcome after SBRT with functional treatment planning in patients with HCC and advanced hepatic cirrhosis: from nuclear medicine to MRI-based functional treatment planning platform.
  • Magnetic resonance imaging-guided versus computed tomography-guided stereotactic body radiotherapy for prostate cancer (MIRAGE): Primary Endpoint Analysis Phase III Randomized Trial
  • Atezolizumab and Stereotactic Body Radiation Therapy in Metastatic, Recurrent, or Persistent Cervical Cancer: Interim Results from a Non-Randomized, Open-Label Phase II Multi-Institutional Study
  • iSABR: Safety and Efficacy Results from a Phase II Study of SABR in Combination with Durvalumab for Early-Stage Medically Inoperable NSCLC
  • Thirteen Years with Preoperative 5x5 Gy in Soft Tissue Sarcomas: A Pattern of Local Failure
  • Stereotactic Ablative Radiation Therapy for Sarcoma Lung Metastases: indications for treatment and patterns of failure
     

06

 GYNAECOLOGY SESSION 

  • A Pilot Study of Moderately Hypo-Fractionated Whole Pelvic Radiotherapy with Concurrent Chemotherapy and Image Guided High Dose Rate Brachytherapy for Locally Advanced Cervical Carcinoma
  • The role of circulating tumor cells as potential predictive and prognostic factors in cervical cancers
  • Definitive High-Dose Radiotherapy for Primary Vulvar Cancer: The DRIVE Multicenter Cohort Study
  • Improved Outcomes with Adjuvant Radiation Therapy in Early-Stage Endometrial Cancer with Abnormal Beta-Catenin Expression
  • Impact of Adjuvant Pelvic External Beam Radiotherapy or Vaginal Brachytherapy on Clinical Outcomes for Early-Stage Uterine Carcinosarcoma
     

GALA DINNER

   Day 02   
   ( 30th July 2023  )  

08

 PHYSICS SESSION 

  • Preclinical research platform for ocular FLASH radiotherapy by Devin Miles, Daniel Sforza, Marisol Cano, James T Handa, John W Wong, Mohammad Rezaee.
  • Correlation of Left Anterior Descending Coronary Artery Radiation Dose with Major Adverse Cardiac Events and Feasibility of Coronary Artery Sparing Treatment Planning in Lung Cancer
  • Pulmonary Function Test Results of Patients Treated on a Two-Institution, 4DCT-Ventilation Functional Avoidance Prospective Clinical Trial
  • Daily Assessment of On-Treatment Tumor Regression by Cone Beam CT as a Prognostic Dynamic Biomarker in Nasopharyngeal Cancer
  • Prospective Clinical Integration of AI Based Treatment Planning tool for whole breast radiation therapy (WBRT): A single institution’s three-year experience
  • Examining the Impact of Direct Patient Care for Medical Physicists: A Randomized Prospective Phase III Trial
  • Deep Learning-Driven Real-Time Liver Tumor Localization Via Optical Surface Imaging and Biomechanical Modeling
  • Spatially Fractionated Radiation Therapy in the Modern Era: The Mayo Clinic Experience
  • SDDRO-DMF: Simultaneous Dose and Dose Rate Optimization with FLASH predictive modeling of Dose Modifying Factor

09

 HEMATOLOGY & PAEDIATRIC 

  • Impact of Myc-Altered Pathology on Radiotherapy Efficacy Among Patients with Relapsed/Refractory Large-B Cell Lymphoma: A Collaborative Retrospective Study
  • Outcomes and Failure Patterns for >500 Patients Treated for Primary CNS Lymphoma: Exploring Modern Roles for Radiotherapy
  • Radiation Therapy for Bridging and Improving CAR-T Cell Therapy
  • Outcomes of Salvage Radiotherapy in Refractory or Relapsed High-Grade B-Cell Lymphoma Patients Treated with Commercial CAR T-Cell Therapy
  • 18FDG PET/CT Parameters for the Prediction of CAR T-Cell Therapy Response among Patients with Large B-Cell Lymphoma
  • Local Failure in Non-metastatic Ewing Sarcoma Patients Treated with Definitive Radiation Therapy on AEWS1031: A Report from the Children’s Oncology Group
  • Volumetric Modulated Arc Therapy Total Body Irradiation (VMAT-TBI) in Pediatric and Adolescent/Young Adult Patients Undergoing Stem Cell Transplantation: Early Outcomes and Toxicities
     

10

 BEYOND SURVIVORSHIP 

  • Does compromising target coverage impact overall survival when treating Oligometastatic Disease with Stereotactic Ablative Radiotherapy (SABR)?
  • FAST-01: Results of the First-In-Human Study of Proton FLASH Radiotherapy
  • Hypofractionated Two Week Short-Course Radiotherapy vs. Monthly Single Fraction Palliative Pelvic Radiation in Advanced Gynaecologic Cancers
  • Patient Reported Outcomes after Frameless Virtual Cone radiosurgery for Trigeminal Neuralgia
  • Penile Bulb Dose Predicts Sexual Quality of Life after Prostate SBRT: Secondary Analysis of a Multi-Institutional Trial

LUNCH

bottom of page